Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 1484-1488, April 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahmad, I.
Right arrow Articles by Allen, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmad, I.
Right arrow Articles by Allen, T. M.

Antibody-targeted Delivery of Doxorubicin Entrapped in Sterically Stabilized Liposomes Can Eradicate Lung Cancer in Mice1

Imran Ahmad, Michael Longenecker, John Samuel and Theresa M. Allen2

Departments of Pharmacology [I. A., T. M. A.] and Immunology [M. L., J. S.], University of Alberta, Edmonton, Alberta, Canada T6G 2H7

Cancer chemotherapy is limited by adverse side effects resulting from toxicities to normal tissues. Targeted delivery of drugs to diseased tissues in vivo would help to reduce these side effects. Liposomes containing lipid derivatives of polyethylene glycol have circulation times sufficiently long to allow for effective in vivo drug delivery. Polyethylene glycol liposomes, containing entrapped doxorubicin, targeted to KLN-205 squamous cell carcinoma of the lung by means of specific antibodies attached at the liposome surface were capable of reducing tumor burden to a high degree and eradicating tumor in a significant percentage of mice.

1 This work was supported by the Medical Research Council of Canada (MA-9127).

2 To whom requests for reprints should be addressed.

Received 12/ 4/92. Accepted 2/18/93.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
C. Brignole, F. Pastorino, D. Marimpietri, G. Pagnan, A. Pistorio, T. M. Allen, V. Pistoia, and M. Ponzoni
Immune Cell-Mediated Antitumor Activities of GD2-Targeted Liposomal c-myb Antisense Oligonucleotides Containing CpG Motifs
J Natl Cancer Inst, August 4, 2004; 96(15): 1171 - 1180.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Pastorino, C. Brignole, D. Marimpietri, P. Sapra, E. H. Moase, T. M. Allen, and M. Ponzoni
Doxorubicin-loaded Fab' Fragments of Anti-disialoganglioside Immunoliposomes Selectively Inhibit the Growth and Dissemination of Human Neuroblastoma in Nude Mice
Cancer Res., January 1, 2003; 63(1): 86 - 92.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-L. Tseng, J.-J. Liu, and R.-L. Hong
Translocation of Liposomes into Cancer Cells by Cell-Penetrating Peptides Penetratin and Tat: A Kinetic and Efficacy Study
Mol. Pharmacol., October 1, 2002; 62(4): 864 - 872.
[Abstract] [Full Text] [PDF]


Home page
J Biomater ApplHome page
R. Banerjee
Liposomes: Applications in Medicine
J Biomater Appl, July 1, 2001; 16(1): 3 - 21.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
S. M. Moghimi, A. C. Hunter, and J. C. Murray
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Pharmacol. Rev., June 1, 2001; 53(2): 283 - 318.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Sugano, N. K. Egilmez, S. J. Yokota, F.-A. Chen, J. Harding, S. K. Huang, and R. B. Bankert
Antibody Targeting of Doxorubicin-loaded Liposomes Suppresses the Growth and Metastatic Spread of Established Human Lung Tumor Xenografts in Severe Combined Immunodeficient Mice
Cancer Res., December 1, 2000; 60(24): 6942 - 6949.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, and D. Papahadjopoulos
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Pharmacol. Rev., December 1, 1999; 51(4): 691 - 744.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R.-L. Hong, C.-J. Huang, Y.-L. Tseng, V. F. Pang, S.-T. Chen, J.-J. Liu, and F.-H. Chang
Direct Comparison of Liposomal Doxorubicin with or without Polyethylene Glycol Coating in C-26 Tumor-bearing Mice: Is Surface Coating with Polyethylene Glycol Beneficial?
Clin. Cancer Res., November 1, 1999; 5(11): 3645 - 3652.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P Nagy, A Jenei, A. Kirsch, J Szollosi, S Damjanovich, and T. Jovin
Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy
J. Cell Sci., January 6, 1999; 112(11): 1733 - 1741.
[Abstract] [PDF]


Home page
ScienceHome page
D. Lasic and D Papahadjopoulos
Liposomes revisited
Science, March 3, 1995; 267(5202): 1275 - 1276.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.